204 related articles for article (PubMed ID: 31319011)
1. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
2. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
3. The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis.
Ju HY; Jang JY; Jeong SW; Woo SA; Kong MG; Jang HY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Jin SY; Kim HS; Kim BS
Clin Mol Hepatol; 2012 Jun; 18(2):213-8. PubMed ID: 22893872
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury.
Tsutsui A; Harada K; Tsuneyama K; Senoh T; Nagano T; Takaguchi K; Ando M; Nakamura S; Mizobuchi K; Kudo M
Dig Dis; 2017; 35(6):506-514. PubMed ID: 29040982
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
Xu HM; Chen Y; Xu J; Zhou Q
World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
[TBL] [Abstract][Full Text] [Related]
6. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
Suzuki A; Brunt EM; Kleiner DE; Miquel R; Smyrk TC; Andrade RJ; Lucena MI; Castiella A; Lindor K; Björnsson E
Hepatology; 2011 Sep; 54(3):931-9. PubMed ID: 21674554
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis.
Wang Q; Selmi C; Zhou X; Qiu D; Li Z; Miao Q; Chen X; Wang J; Krawitt EL; Gershwin ME; Han Y; Ma X
J Autoimmun; 2013 Mar; 41():140-5. PubMed ID: 23187010
[TBL] [Abstract][Full Text] [Related]
8. [Drug-induced autoimmune-like liver injury].
Weber S
Inn Med (Heidelb); 2024 Apr; 65(4):334-339. PubMed ID: 38374310
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure.
Zhu B; You SL; Wan ZH; Liu HL; Rong YH; Zang H; Xin SJ
World J Gastroenterol; 2014 Jun; 20(23):7473-9. PubMed ID: 24966618
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
[TBL] [Abstract][Full Text] [Related]
12. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.
de Boer YS; Kosinski AS; Urban TJ; Zhao Z; Long N; Chalasani N; Kleiner DE; Hoofnagle JH;
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):103-112.e2. PubMed ID: 27311619
[TBL] [Abstract][Full Text] [Related]
13. A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.
Assis DN; Takahashi H; Leng L; Zeniya M; Boyer JL; Bucala R
Dig Dis Sci; 2016 Dec; 61(12):3506-3512. PubMed ID: 27696094
[TBL] [Abstract][Full Text] [Related]
14. A case of synthetic oestrogen-induced autoimmune hepatitis with microvesicular steatosis.
Morii K; Nishisaka M; Nakamura S; Oda T; Aoyama Y; Yamamoto T; Kishida H; Okushin H; Uesaka K
J Clin Pharm Ther; 2014 Oct; 39(5):573-6. PubMed ID: 24989642
[TBL] [Abstract][Full Text] [Related]
15. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.
Sebode M; Schulz L; Lohse AW
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895915
[TBL] [Abstract][Full Text] [Related]
16. The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive Review.
Wang Z; Sheng L; Yang Y; Yang F; Xiao X; Hua J; Guo C; Wei Y; Tang R; Miao Q; Zhang J; Li Y; Fang J; Qiu D; Krawitt EL; Bowlus CL; Gershwin ME; Wang Q; Ma X
Clin Rev Allergy Immunol; 2017 Jun; 52(3):424-435. PubMed ID: 27515672
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of autoimmune hepatitis after liver transplantation without elevation of alanine aminotransferase.
Yao H; Michitaka K; Tokumoto Y; Murata Y; Mashiba T; Abe M; Hiasa Y; Horiike N; Onji M
World J Gastroenterol; 2007 Mar; 13(10):1618-21. PubMed ID: 17461459
[TBL] [Abstract][Full Text] [Related]
18. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
Hisamochi A; Kage M; Ide T; Arinaga-Hino T; Amano K; Kuwahara R; Ogata K; Miyajima I; Kumashiro R; Sata M; Torimura T
J Gastroenterol; 2016 Jun; 51(6):597-607. PubMed ID: 26519284
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of severe and fulminant forms of autoimmune hepatitis.
Yasui S; Fujiwara K; Yonemitsu Y; Oda S; Nakano M; Yokosuka O
J Gastroenterol; 2011 Mar; 46(3):378-90. PubMed ID: 20821236
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey.
Joshita S; Yoshizawa K; Umemura T; Ohira H; Takahashi A; Harada K; Hiep NC; Tsuneyama K; Kage M; Nakano M; Kang JH; Koike K; Zeniya M; Yasunaka T; Takaki A; Torimura T; Abe M; Yokosuka O; Tanaka A; Takikawa H;
J Gastroenterol; 2018 Sep; 53(9):1079-1088. PubMed ID: 29476251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]